In a recent meta-analysis by Gan et al. that evaluated the prognostic value of HER2 in bladder cancer, it was reported that the HER2 gene was not associated with OS, disease-specific survival, or progression-free survival, but it was related to advanced pathological stage, high tumor grade, and tumor recurrence [10]. The gene discussed is ERBB2; the disease is urinary bladder carcinoma.